Arrogene is led by a highly trained and distinguished team of experts who have demonstrated success in the combined fields of research, medicine, biologics, neuroscience, and nanotechnology along with the specialized business development track record requisite for the launch of cutting-edge medical technologies.


Eggehard Holler, PhD

Dr. Holler serves as Professor of Neurosurgery at Cedars-Sinai Medical Center and Professor of Biochemistry at the University of Regensburg, Germany. Dr. Holler’s internationally renowned research focuses on design, synthesis and characterization of novel nanoscale drug delivery systems based on polymalic acid.

Alexander Ljubimova, PhD

Dr. Alexander Ljubimov serves as Director of the Eye Program, Regenerative Medicine Institute, and as Professor of Biomedical Sciences and Neurosurgery at Cedars-Sinai Medical Center. He is also Professor of Medicine at the University of California Los Angeles David Geffen School of Medicine.

Board of Directors

Jack Kavanaugh, MD, MBA

Chairman of the Board

Dr. Kavanaugh’s expertise has focused on the health and science technology sector, capitalizing on his background in medicine and business to lead mergers, acquisitions, turnarounds, and corporate strategic development and initiatives.